Patient-Centered Analytics Tools and technologies to enable patient centered insight

Similar documents
SEEKING PATIENT PERSPECTIVES IN CLINICAL TRIAL DESIGN AMY FROMENT, GLOBAL FEASIBILITY OPERATIONS DIR THE PATIENT S VOICE 2017

Reducing the High Cost of Patient Non-Adherence:

RPS Strategy

7/13/2017. Learning objectives. The Internet of Things. Internet of Things: evolving methods for interacting

Toward Patient-Centric Marketing

PERSPECTIVE. Ready for the Digital Service Design Revolution? A new path to collaborative, holistic and intuitive care

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Corporate plan Moving towards better regulation. Page 1

Specialty Pharmacy: What You Need To Know. William Pong, Pharm.D., MBA

SAVE OUR NHS TIME FOR ACTION ON SELF CARE. Dr Beth McCarron- Nash Self Care Forum Board member, GPC negotiator

Patient First Drug Development:

NHS Digital Academy Experience and Advice from Cohort 1

The NHS Confederation s Decisions of Value

Stage 2 GP longitudinal placement learning outcomes

Using Twitter to Engage Nurses in Policy Debate to Inform Health Strategy

Patient information and how patient advocacy can strengthen education and best practice

Real World Evidence in Europe

Leveraging the EHR to Connect Physicians and Consumers

What Happens to the Clinical Lab Industry as:

The Future of Pharma: Patients Rising to the Core

The future of social care funding. Can a green paper solve all the problems?

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

The big-data revolution in US health care: Accelerating value and innovation

qlegal Application Information

LOST IN TRANSLATION:

General Information about radiotherapy

JOB DESCRIPTION JOB DESCRIPTION

Integrated leadership for physicians, health care executives, hospitals and health systems

Health Technology Assessment.

New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report

Institute for Health Policy and Practice. Strategic Plan

Future of Community Healthcare Providers. Author: Mr. Raj Shah, CEO, CTIS Inc.

Transforming hospice care A five-year strategy for the hospice movement 2017 to 2022

Bexley Whole Health System Fellows. Development opportunities for recently qualified GPs. December 2017

Patient Empowerment. Kostas Aligiannis, Policy Officer, European Patients Forum eupatientsforum

FIP STATEMENT OF POLICY Pharmacy: Gateway to Care

Are you at risk of blood clots?

Oral Ibrutinib (single agent)

Innovation in Action September 2016

Where the Candidate Journey Begins

Newham I-QAF. Newham Integrated Quality Assessment Framework

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

The Association for Individual Development. A Core Solutions Case Study

Big data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

YOUR PERSONALIZED COMPENSATION STATEMENT. making the most of your employment rewards. This page is generated by Fringe Facts.

Patient Advocate Certification Board. Competencies and Best Practices required for a Board Certified Patient Advocate (BCPA)

Report extract: Integrated Delivery Networks in the US

E-Learning Module M: Assessment Review

Your health, handled with care. Executive Healthcare Programme. Welcome

AN OVERVIEW OF THE CLINICAL TRIAL ENGAGEMENT NETWORK

National Nursing Informatics Deep Dive Program

Learning Briefs: Equity in Specialty Care

Patients as consumers: How engaged patients could reshape health care

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

AMGEN S APPROACH TO VALUE- BASED HEALTHCARE IN EUROPE

The Vision for the Future

NHS. NHS Improvement CANCER. Discovery Interview : Hints and Tips. The Power of Stories DIAGNOSTICS HEART LUNG STROKE

WORKING TOGETHER WITH PATIENT GROUPS

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

CME Disclosure. Accreditation Statement. Designation of Credit. Disclosure Policy

Coastal Medical, Inc.

Buttle UK. Chief Executive Officer. Candidate Information Pack

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE) SYLLABUS (Revised February 2013, Approved April 2013)

What s Next: People-Powered Knowledge Generation from Digital Data

Care Redesign: Budgeted Episodes for Total Knee Replacement

SMG OB/GYN Lake Lansing St. Johns Returning Patient Questionnaire (Please print clearly and Fill out Entirely)

Faculty of Health, Social Care & Education. BSc (Hons) RN. Insight into Adult Nursing for Mental Health Nursing students v1.0

Current Trends in Business Process Outsourcing

Improvement and assessment framework for children and young people s health services

Singapore Healthcare Management Congress 2012

Eating Disorder Services

Allied Health Worker - Occupational Therapist

Mission, Vision & Core Values:

Minnesota CHW Curriculum

Engage students looking for. the best. university match. all around the world

Confronting the Challenges of Rare Disease:

Measuring Outcomes. The Key to Value-Based Health Care

North School of Pharmacy and Medicines Optimisation Strategic Plan

Streamlining care processes with a data-driven approach

Will the Robots take care of Grandma? Jerry A. Jacobs University of Pennsylvania June 2018

ISANSYS LIFECARE LTD CLOUD COMPUTING TECHNOLOGY TO MONITOR PATIENTS VITAL SIGNS

Implementing a Real-Time Survey System and the 6E Framework

8 Factors for Success in the Transition to Value-Based Care

Allied Health - Occupational Therapist

Improving Healthcare and Patient Outcomes Through Connected Devices

Coordinated cancer care: better for patients, more efficient. Background

Why aren t we all using Real-World Evidence if it is so insightful and powerful? Because it is difficult to generate. Introducing E360 by IMS Health

INNOVATIONS IN CARE MANAGEMENT. Michael Burcham, Narus Health

Holistic Needs Assessment (HNA) for Adult Cancer Patients Guidelines

Paediatric Pharmaceutical Care: Internships and Placements

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

Transforming Louisiana s Long Term Care Supports and Services System. Initial Program Concept

Using the patient s voice to measure quality of care

Optum capability landscape. Modernising infrastructure. Advancing care. Empowering consumers.

APRIL Center on Aging TABLE OF CONTENTS. 253 Justin Hall Manhattan, KS (785)

Population Centric Intelligence: Using Data Segmentation and Community Health Assessments for Better Patient Insights

Transcription:

Patient-Centered Analytics Tools and technologies to enable patient centered insight Nina Mian, Head of Biomedical Informatics Advanced Analytics Center, AstraZeneca April 2015

The Advanced Analytics Centre Transforming drug development decision making through applied data science

Patient centered analytics? Solicit and acquire patient views & data Derive insight from data: analytics Deliver actionable insights to AstraZeneca and patients 3

Challenges you might have come across...

..and why we need to resolve them Motivation to do great things for patients Impact of disease Status of current treatment Unmet need Endpoints that matter Recruitment & retention Reducing missing data Adherence + efficacy Benefit-Risk (tolerability) Transparency True patient journey Patient group education and advocacy Brand awareness Medicines Access Improved health outcomes & experiences 5

Data & Insights Active and passive Tools & Technologies Peak of Inflated Expectation Forums PRO/ PRE YouTube Patient health record Biomarkers Blogs Podcasts Consumer reports Location and movement Searches Mobile Social Wearable http://commons.wikimedia.org/wiki/category:hype_cycle 6

PatientsLikeMe 7

Ovarian Cancer In your own words Total # 30 (56.3 ± 9.2 y.o) Caucasian females BRCA+ n = 4 BRCA - n = 11 BRCA Unknown n = 15 8 Treatment pathway

The approach Structured Longitudinal Targeted additional data Fast Account for bias (population, recall) Where the patients already are 9

Patient centric learning Listening, and understanding what patients are willing to share I spent Sunday in bed shaking off a headache and feeling unwell. the rash is gone from my face and is greatly reduced on my chest... My skin continues to be dry but is responding to XXX and is not a problem. Still there has been no return of the swelling to my ankle or foot and No discomfort while eating. So I'm in pretty good shape really the taste of the pills is unpleasant even though they are in the mouth for only a couple of seconds,... I'm not doing an awful lot because of the fatigue that is really quite, quite overwhelming. 10

Insight to Interpretation Safety Skin Gastrointestinal Dry skin Pimply rash Diarrhoea Constipation 11

How does it help the patients? How does it help us? Characterisation of issues Impact Management Informed medical teams Informed patients Gives our patients a voice, and us a way to listen, so that we can strengthening the link between our science and patient-driven needs 12

Finalist: Customer Innovator Award

Me&My: Global Patient and Physician Support Key Modules Patient Profiling based on behaviour and disease state guides messaging strategy and other interventions Data Collection from Patients Integration of devices for adherence support and detecting change in disease state Devices to collect physiological data Patient reported outcomes Supported self management Individualised messages based on data collected Content from medically valid sources Goal setting and tracking Decision support Links to HCP and HCP services

Navigating the trough of disillusionment 15

https://www.theranos.com/ https://www.aicure.com/ > Patients making medical decisions > New methods of data capture > Holistic view of patient experience Patient + Provider + Payer + Pharma Improved health outcomes & experience http://www.thecyranosmccann.com/

Acknowledgements Jenny Royle, Patient Safety Åsa Strom, Clinical informatics, R&D Information Stephanie Roberts, Advanced Analytics Center Christelle Gendrin, Advanced Analytics Center Amrik Mahal, R&D Information Lili Peng, R&D Information Donal Landers, Early Clinical Development Andrew Hughes, Early Clinical Development Shirley Spratt, Patient Safety Katarina Halling, PRO Group Daniel Eek, PRO Group Lisa Banks, Intelligent Pharmaceuticals Matt Bonam, Intelligent Pharmaceuticals Jan Frövenholt, R&D Information Sarah Keegans, Intelligent Pharmaceuticals Our partners at PLM and many other collaborators. 17

Confidentiality Notice This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 2 Kingdom Street, London, W2 6BD, UK, T: +44(0)20 7604 8000, F: +44 (0)20 7604 8151, www.astrazeneca.com 18